Trial
NCT00321698
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
—
Condition
Prostate Cancer
Intervention
Intensity-Modulated Radiation Therapy (IMRT)
Why stopped
Funding withdrawal
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-29